Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
The most recent Ebola outbreak demonstrated a clear lack of preparedness from the global health and humanitarian system
for an outbreak of infectious diseases and a number of weakness in the international health and emergency response
infrastructure. The first case of the outbreak occurred in December 2013 in Melinda in southeastern Guinea but was only
confirmed as Ebola in March of 2014. It is clear that a number of factors affected the nature of the response and that any
possible combination of these factors could occur. During the post Ebola recovery period and in the interest of our study,we
approached key stakeholders from relevant response organizations who were asked to describe how their organizations would
have responded to case study scenario in which a non-state actor claims responsibility for new cases of Ebola in an adjacent
geographical area with a previously unexposed population just like it was the case in Guinee, Libera and Sierrea Leone just
before the outbreak. The study subsequently sought the views of major bilateral donors to the Ebola response to better to better
understand the challenges and approaches nations would take in the event of a deliberate use and its impact on humanitarian
disaster response. Our engagement amid to bring together a selected group of multi-sector participants to glean what has been
learned so far and develop firm proposals for action. Whatever the next event or outbreak is and regardless of its source, the
Ebola outbreak revealed weakness in the global health and humanitarian responses that must be fixed. Coordination between
agencies should be increased and efforts should be engineered into the system and coordination to allow for the international
community to provide what is needed, when it is needed, rather than everything at once.
Biography
Serge Blaise Emaleu is a medical doctor(M.D) and trained surgeon with over 20 years of experience. He also specialized in infectious disease/immunology through the interdisciplinary post-doctoral training program at Stanford University School of Medicine in California(USA). In 2012 He joined the Harvard School of the public in Boston Massachusetts (USA) to study the Approaches to Infection Prevention and Control (IPC) in Healthcare Settings.